These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29259008)

  • 1. CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.
    Klein S; Abraham M; Bulvik B; Dery E; Weiss ID; Barashi N; Abramovitch R; Wald H; Harel Y; Olam D; Weiss L; Beider K; Eizenberg O; Wald O; Galun E; Pereg Y; Peled A
    Cancer Res; 2018 Mar; 78(6):1471-1483. PubMed ID: 29259008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.
    Abraham M; Klein S; Bulvik B; Wald H; Weiss ID; Olam D; Weiss L; Beider K; Eizenberg O; Wald O; Galun E; Avigdor A; Benjamini O; Nagler A; Pereg Y; Tavor S; Peled A
    Leukemia; 2017 Nov; 31(11):2336-2346. PubMed ID: 28280274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
    Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
    Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
    Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
    Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
    Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
    Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
    Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
    Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.
    Bonci D; Coppola V; Musumeci M; Addario A; Giuffrida R; Memeo L; D'Urso L; Pagliuca A; Biffoni M; Labbaye C; Bartucci M; Muto G; Peschle C; De Maria R
    Nat Med; 2008 Nov; 14(11):1271-7. PubMed ID: 18931683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.
    Soriano A; Masanas M; Boloix A; Masiá N; París-Coderch L; Piskareva O; Jiménez C; Henrich KO; Roma J; Westermann F; Stallings RL; Sábado C; de Toledo JS; Santamaria A; Gallego S; Segura MF
    Cell Mol Life Sci; 2019 Jun; 76(11):2231-2243. PubMed ID: 30770954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.
    Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S
    Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Csk homologous kinase inhibits CXCL12-CXCR4 signaling in neuroblastoma.
    Zagozdzon R; Fu Y; Avraham HK
    Int J Oncol; 2008 Mar; 32(3):619-23. PubMed ID: 18292939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of the oncogene lncRNA NEAT1 restores the availability of
    Hu Y; Yang Q; Wang L; Wang S; Sun F; Xu D; Jiang J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
    Zhu Y; Wen X; Zhao P
    Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer.
    Wang L; Zhang X; Sheng L; Qiu C; Luo R
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth.
    Lamers F; Schild L; den Hartog IJ; Ebus ME; Westerhout EM; Ora I; Koster J; Versteeg R; Caron HN; Molenaar JJ
    Eur J Cancer; 2012 Nov; 48(16):3093-103. PubMed ID: 22366560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.
    Cai CK; Zhao GY; Tian LY; Liu L; Yan K; Ma YL; Ji ZW; Li XX; Han K; Gao J; Qiu XC; Fan QY; Yang TT; Ma BA
    Oncol Rep; 2012 Nov; 28(5):1764-70. PubMed ID: 22922827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
    Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
    Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.
    Hart LS; Rader J; Raman P; Batra V; Russell MR; Tsang M; Gagliardi M; Chen L; Martinez D; Li Y; Wood A; Kim S; Parasuraman S; Delach S; Cole KA; Krupa S; Boehm M; Peters M; Caponigro G; Maris JM
    Clin Cancer Res; 2017 Apr; 23(7):1785-1796. PubMed ID: 27729458
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
    Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
    J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma.
    He XY; Tan ZL; Mou Q; Liu FJ; Liu S; Yu CW; Zhu J; Lv LY; Zhang J; Wang S; Bao LM; Peng B; Zhao H; Zou L
    Clin Cancer Res; 2017 Jun; 23(11):2905-2918. PubMed ID: 28003306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.